Civic Intelligence

National Institute for Pharmaceutical Technology and Education

EIN 26-0636598 • 501(c)3 • Minneapolis, MN

Profile

The mission of National Institute for Pharmaceutical Technology and Education(NIPTE) is to improve the way medicines are designed, developed and manufactured to meet the needs of patients in the 21st century.

717 Delaware Street SE Suite 477Minneapolis, MN 55414

www.nipte.org

Siviq Scores

Precomputed percentiles relative to similar nonprofits. These scores are descriptive rather than judgmental.

Liabilities / Assets

91st percentile

0.85x

Higher debt load relative to assets than 91% of similar nonprofits.

501(c)3 • $1M-$5M nonprofits • Source year 2024

Liabilities / Revenue

87th percentile

0.87x

Higher debt load relative to revenue than 87% of similar nonprofits.

501(c)3 • $1M-$5M nonprofits • Source year 2024

Net Margin

10th percentile

-32%

Higher net margin than 10% of similar nonprofits.

501(c)3 • $1M-$5M nonprofits • Source year 2024

Top Officer Pay

97th percentile

$492,408

Higher top officer pay than 97% of similar nonprofits.

Top officer pay equals 16.2% of source-year revenue.

501(c)3 • $1M-$5M nonprofits • Source year 2024

Asset Growth

96th percentile

129%

Faster asset growth than 96% of similar nonprofits.

501(c)3 • $1M-$5M nonprofits • Annualized from 2023 to 2024

Revenue Growth

91st percentile

104%

Faster revenue growth than 91% of similar nonprofits.

501(c)3 • $1M-$5M nonprofits • Annualized from 2023 to 2024

Assets

Up

$3,127,427

Up $2,059,431 (+193%) from 2022

Liabilities

Up

$2,645,140

Up $2,400,168 (+980%) from 2022

Net Assets

Down

$482,287

Down $340,737 (-41%) from 2022

Revenue

Up

$3,032,204

Up $2,034,188 (+204%) from 2022

Expenses

Up

$3,987,921

Up $2,837,044 (+247%) from 2022

Net Income

Down

-$955,717

Down $802,856 (-525%) from 2022

Trend Graphs

Balance Sheet Trend

Grouped bars show assets, liabilities, and net assets across loaded filings.

$8.0M$6.0M$4.0M$2.0M$0Assets 2011: $561,332Liabilities 2011: $232,274Net Assets 2011: $329,0582011Assets 2018: $6,832,797Liabilities 2018: $5,478,969Net Assets 2018: $1,353,8282018Assets 2021: $1,296,895Liabilities 2021: $304,024Net Assets 2021: $992,8712021Assets 2022: $1,067,996Liabilities 2022: $244,972Net Assets 2022: $823,0242022Assets 2024: $3,127,427Liabilities 2024: $2,645,140Net Assets 2024: $482,2872024

Highlighted filing

2024

Assets$3,127,427
Liabilities$2,645,140
Net Assets$482,287

Operations Trend

Revenue, expenses, and net income by year, with the latest filing highlighted.

$4.0M$2.0M$0-$2.0MExpenses 2011: $1,327,3662011Revenue 2018: $3,201,579Expenses 2018: $3,225,800Net Income 2018: -$24,2212018Revenue 2021: $1,189,720Expenses 2021: $1,211,781Net Income 2021: -$22,0612021Revenue 2022: $998,016Expenses 2022: $1,150,877Net Income 2022: -$152,8612022Revenue 2024: $3,032,204Expenses 2024: $3,987,921Net Income 2024: -$955,7172024

Highlighted filing

2024

Revenue$3,032,204
Expenses$3,987,921
Net Income-$955,717

Filings

Latest Filing Detail
Jump To
Filing Snapshot
Filing Period
Jul 1, 2023 to Jun 30, 2024
Signed
May 13, 2025
Return Version
2023v6.0
Gross Receipts
$3,032,204
Mission and Program Overview

Mission

The National Institute for Pharmaceutical Technology and Education (NIPTE) is a collaboration of academia, industry and other stakeholders using research, outreach and education to support the mission. NIPTE leverages scientific and technological advances to bring confidence and reliability for pharmaceutical products to consumers worldwide. NIPTE's mission is to improve the way medicines are designed, developed and manufactured to meet the needs of patients in the 21st century.

The National Institute for Pharmaceutical Technology and Education (NIPTE) is a premier consortium of top universities working to advance pharmaceutical science, technology, and manufacturing. We collaborate with industry and regulatory agencies to drive innovation, enhance drug development efficiency, and strengthen the pharmaceutical workforce. Our research and education initiatives support modernized manufacturing, regulatory science, and supply chair resilience-ensuring safer, more effective, and more accessible medicines for patients. Through NIPTE, industry leaders and policymakers gain access to cutting-edge science and highly skilled talent pipeline, fostering a more robust and competitive pharmaceutical sector.

Balance Sheet Detail
LineBeginningEndChange
Assets
Pledges and Grants Receivable$304,859$2,150,049▲ $1,845,190
Savings and Temporary Cash Investments$945,680$1,122,544▲ $176,864
Cash and Non-Interest-Bearing Accounts$117,731$-145,166▼ $262,897
Total Assets$1,368,270$3,127,427▲ $1,759,157
Liabilities
Accounts Payable and Accrued Expenses$112,656$2,621,200▲ $2,508,544
Grants Payable$479,093--
Deferred Revenue$171,627--
Other Liabilities-$23,940-
Total Liabilities$763,376$2,645,140▲ $1,881,764
Net Assets / Fund Balance
Net Assets Without Donor Restrictions$604,894$482,287▼ $122,607
Net Assets With Donor Restrictions$0$0→ $0
Total Net Assets Fund Balance$604,894$482,287▼ $122,607
Total Liabilities and Net Assets / Fund Balance$1,368,270$3,127,427▲ $1,759,157
Compensation and Service Providers

Board Members and Trustees

NameTitle
James K DrennenChair
Philip HritckoVice Chair
Alberto CuitinoBoard Member
Amy PittingerBoard Member
Arash T DebastaniBoard Member
Barbara TimmermannBoard Member
Eric L BarkerBoard Member
Kevin CasselBoard Member
Martin S ZandBoard Member
Paul BryceBoard Member
Sarah MichelBoard Member
Vicki EllingrodBoard Member
Wanda MaldonadoBoard Member
Vadim J GurvichExective Director
Kelechi C OgbonnaSecretary
Donna StrumTreasurer
Revenue and Support

Revenue Composition

Contributions and Grants
$1,911,365
Program Service Revenue
$1,072,268
Investment Income
$48,079
Other Revenue
$492
All Other Contributions
$43,900
Change in Net Assets
$-955,717
Expenses and Functional Allocation

Major Expense Lines

Line ItemAmount
Grants and Similar Amounts Paid$3,663,653
Other Expenses$324,268
Professional Fundraising Fees$0
Salaries, Compensation, and Employee Benefits$0
Total Fundraising Expense$0

Functional Expense Allocation

Line ItemProgramManagementFundraisingTotal
Grants to Domestic Orgs$2,888,651--$2,888,651
Foreign Grants$775,002--$775,002
Fees for Services Management-$173,209-$173,209
Conferences and Meetings$62,255$3,079-$65,334
Other Expenses$40,000$0$0$40,000
Travel$10,969--$10,969
Information Technology$8,127$903-$9,030
Fees for Services Other$5,000$3,100-$8,100
Fees for Services Accounting-$8,047-$8,047
Office Expenses$2,165$241-$2,406
Occupancy-$2,220-$2,220
Advertising$1,733--$1,733
Insurance-$1,668-$1,668
Fees for Services Legal-$1,035-$1,035
All Other Expenses$151$366-$517
Total Functional Expenses$3,794,053$193,868$0$3,987,921
International Activity

Grant and Assistance Recipients

RecipientLocationCategoryPurposeAmount
Rutgers UniversityPiscataway, NJ-FDA subgrant awards for pharmaceutical research$1,171,170
Virginia Commonwealth UniversityRichmond, VA-FDA subgrant awards for pharmaceutical research$581,061
University of MinnesotaMinneapolis, MN-FDA subgrant awards for pharmaceutical research$370,644
Massachusetts Institute of TechnologyCambridge, MA-FDA subgrant awards for pharmaceutical research$297,547
University of IowaIowa City, IA-FDA subgrant awards for pharmaceutical research$240,009
Northeastern UniversityBoston, MA-FDA subgrant awards for pharmaceutical research$85,896
Purdue UniversityWest Lafayette, IN-FDA subgrant awards for pharmaceutical research$77,058
Duquesne UniversityPittsburgh, PA-FDA subgrant awards for pharmaceutical research$32,777
University of ConnecticutStorrs, CT-FDA subgrant awards for pharmaceutical research$17,845
University of Puerto RicoSan Juan, PR-FDA subgrant awards for pharmaceutical research$16,644

International Compliance

Activity in boycott countries
No
Foreign corporation ownership
No
Foreign partnership interest
No
Interest in foreign trust
No
Passive foreign investment company interest
No
Transfers to foreign corporations
No
Fundraising, Events, and Gaming
Fundraising activities
No
Gaming activities
No
Professional fundraiser used
No

Fundraising and Gaming Totals

Line ItemAmount
Professional Fundraising Fees$0
Political and Lobbying Activity
Political campaign activity
No
Lobbying activity
No
Subject to proxy tax
No
Debt and Bond Financing

Other Reported Liabilities

LiabilityAmount
Refundable Advance$23,940
Governance and Compliance

Governance Checklist

Compiled or reviewed by an accountant
No
Annual disclosure for covered persons
Yes
Backup withholding compliance
Yes
Business relationship with 35% controlled entity
No
Business relationship with family members
No
Business relationship with organization members
No
Material changes to governing documents
No
Compensation from other sources disclosed
No
CEO compensation reviewed
Yes
Other officer compensation reviewed
No
Conflict-of-interest policy
Yes
Audited financial statements prepared
No
Key decisions subject to board approval
No
Management duties delegated
No

Governance Explanations

Form 990, Part VI, Section A, Line 6

The Organization has member institutions.

Form 990, Part VI, Section A, Line 7A

Board members are elected by the member institutions. Officers are elected by board members.

Form 990, Part VI, Section B, Line 11B

First, the accounting personnel reviews the 990 for accuracy and consistency with the books. Second, the Executive Director reviews. Third, the Finance and Audit Committee reviews. After all reviews (and any corrections are made), the Executive Director signs the final version.

Form 990, Part VI, Section B, Line 15

The current Executive Director is employed by the University of Minnesota, and the University determines his compensation. The role is contracted to NIPTE, who pays the University for his time.

Form 990, Part VI, Section C, Line 19

The Organization makes its governing documents, policies, and financial documents available upon request.

Filing and Contact Details

Filer

Filer Name
National Institute for Pharmaceutical Technology and Educa
EIN
26-0636598
Phone
6126266650
Address
717 Delaware Street SE Suite 477, Minneapolis, MN 55414

Signing Officer

Name
Vadim J Gurvich
Title
Executive Director
Phone
6126266650
Signed
2025-05-13
Discuss with paid preparer
Yes

Organization Details

Principal Officer
Vadim J Gurvich
Formed
2007
Legal Domicile
In
Voting Board Members
15
Independent Board Members
0
Employees
0
Volunteers
0

Preparer

Firm
BWK Rogers PC
Address
431 South 7th Street Suite 2424, Minneapolis, MN 55415
Preparer
Melissa J Baraibar
Phone
6123325446
Supplemental Narrative

Additional Explanations

Form 990, Part XII, Line 3B

Additional time was needed to ensure the records were ready to be audited by our independent CPA. The audit testing is scheduled to be completed yet this month with a goal of having the report completed and submitted in the next two months.

Raw XML AppendixShowing 400 of 1,239 raw XML fields

This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.

Path#Value
IRS990/AccountantCompileOrReviewInd00
IRS990/AccountsPayableAccrExpnssGrp/BOYAmt0112656
IRS990/AccountsPayableAccrExpnssGrp/EOYAmt02621200
IRS990/ActivitiesConductedPrtshpInd00
IRS990/ActivityOrMissionDesc0The National Institute for Pharmaceutical Technology and Education (NIPTE) is a premier consortium of top universities working to advance pharmaceutical science, technology, and manufacturing. We collaborate with industry and regulatory agencies to drive innovation, enhance drug development efficiency, and strengthen the pharmaceutical workforce. Our research and education initiatives support modernized manufacturing, regulatory science, and supply chair resilience-ensuring safer, more effective, and more accessible medicines for patients. Through NIPTE, industry leaders and policymakers gain access to cutting-edge science and highly skilled talent pipeline, fostering a more robust and competitive pharmaceutical sector.
IRS990/AdvertisingGrp/ProgramServicesAmt01733
IRS990/AdvertisingGrp/TotalAmt01733
IRS990/AllOtherContributionsAmt043900
IRS990/AllOtherExpensesGrp/ManagementAndGeneralAmt0366
IRS990/AllOtherExpensesGrp/ProgramServicesAmt0151
IRS990/AllOtherExpensesGrp/TotalAmt0517
IRS990/AnnualDisclosureCoveredPrsnInd01
IRS990/BackupWthldComplianceInd01
IRS990/BooksInCareOfDetail/BusinessName/BusinessNameLine1Txt0The Organization
IRS990/BooksInCareOfDetail/PhoneNum06126266650
IRS990/BooksInCareOfDetail/USAddress/AddressLine1Txt0717 Delaware Street SE Suite 477
IRS990/BooksInCareOfDetail/USAddress/CityNm0Minneapolis
IRS990/BooksInCareOfDetail/USAddress/StateAbbreviationCd0MN
IRS990/BooksInCareOfDetail/USAddress/ZIPCd055414
IRS990/BusinessRlnWith35CtrlEntInd00
IRS990/BusinessRlnWithFamMemInd00
IRS990/BusinessRlnWithOrgMemInd00
IRS990/CashNonInterestBearingGrp/BOYAmt0117731
IRS990/CashNonInterestBearingGrp/EOYAmt0-145166
IRS990/ChangeToOrgDocumentsInd00
IRS990/CntrctRcvdGreaterThan100KCnt00
IRS990/CollectionsOfArtInd00
IRS990/CompensationFromOtherSrcsInd00
IRS990/CompensationProcessCEOInd01
IRS990/CompensationProcessOtherInd00
IRS990/ConferencesMeetingsGrp/ManagementAndGeneralAmt03079
IRS990/ConferencesMeetingsGrp/ProgramServicesAmt062255
IRS990/ConferencesMeetingsGrp/TotalAmt065334
IRS990/ConflictOfInterestPolicyInd01
IRS990/ConservationEasementsInd00
IRS990/ConsolidatedAuditFinclStmtInd00
IRS990/ContriRptFundraisingEventAmt00
IRS990/CreditCounselingInd00
IRS990/CYBenefitsPaidToMembersAmt00
IRS990/CYContributionsGrantsAmt01911365
IRS990/CYGrantsAndSimilarPaidAmt03663653
IRS990/CYInvestmentIncomeAmt048079
IRS990/CYOtherExpensesAmt0324268
IRS990/CYOtherRevenueAmt0492
IRS990/CYProgramServiceRevenueAmt01072268
IRS990/CYRevenuesLessExpensesAmt0-955717
IRS990/CYSalariesCompEmpBnftPaidAmt00
IRS990/CYTotalExpensesAmt03987921
IRS990/CYTotalFundraisingExpenseAmt00
IRS990/CYTotalProfFndrsngExpnsAmt00
IRS990/CYTotalRevenueAmt03032204
IRS990/DecisionsSubjectToApprovaInd00
IRS990/DeductibleArtContributionInd00
IRS990/DeductibleNonCashContriInd00
IRS990/DeferredRevenueGrp/BOYAmt0171627
IRS990/DelegationOfMgmtDutiesInd00
IRS990/Desc0These projects support NIPTE's mission to make medicines more affordable and of higher quality. In addition, NIPTE supported the education component by developing and delivering advanced pharmaceutical topics to the workforce.
IRS990/DescribedInSection501c3Ind01
IRS990/DisregardedEntityInd00
IRS990/DocumentRetentionPolicyInd01
IRS990/DonatedServicesAndUseFcltsAmt00
IRS990/DonorAdvisedFundInd00
IRS990/DonorRestrictionNetAssetsGrp/BOYAmt00
IRS990/DonorRestrictionNetAssetsGrp/EOYAmt00
IRS990/DonorRstrOrQuasiEndowmentsInd00
IRS990/ElectionOfBoardMembersInd01
IRS990/EmployeeCnt00
IRS990/EngagedInExcessBenefitTransInd00
IRS990/ExpenseAmt03794053
IRS990/FamilyOrBusinessRlnInd00
IRS990/FederalGrantAuditPerformedInd00
IRS990/FederalGrantAuditRequiredInd01
IRS990/FederatedCampaignsAmt00
IRS990/FeesForServicesAccountingGrp/ManagementAndGeneralAmt08047
IRS990/FeesForServicesAccountingGrp/TotalAmt08047
IRS990/FeesForServicesLegalGrp/ManagementAndGeneralAmt01035
IRS990/FeesForServicesLegalGrp/TotalAmt01035
IRS990/FeesForServicesManagementGrp/ManagementAndGeneralAmt0173209
IRS990/FeesForServicesManagementGrp/TotalAmt0173209
IRS990/FeesForServicesOtherGrp/ManagementAndGeneralAmt03100
IRS990/FeesForServicesOtherGrp/ProgramServicesAmt05000
IRS990/FeesForServicesOtherGrp/TotalAmt08100
IRS990/ForeignActivitiesInd00
IRS990/ForeignFinancialAccountInd00
IRS990/ForeignGrantsGrp/ProgramServicesAmt0775002
IRS990/ForeignGrantsGrp/TotalAmt0775002
IRS990/ForeignOfficeInd00
IRS990/Form8282PropertyDisposedOfInd00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt040
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt140
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt240
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt340
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt440
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt540
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt640
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt740
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt840
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt940
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt1020
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt1140
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt1240
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt1340
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt1440
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt1540
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt01
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt11
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt21
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt31.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt41
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt51
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt61
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt71
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt81
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt91
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt1020
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt111
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt121
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt131
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt141
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt151
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd0X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd1X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd2X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd3X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd4X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd5X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd6X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd7X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd8X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd9X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd10X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd11X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd12X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd13X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd14X
IRS990/Form990PartVIISectionAGrp/OfficerInd0X
IRS990/Form990PartVIISectionAGrp/OfficerInd1X
IRS990/Form990PartVIISectionAGrp/OfficerInd2X
IRS990/Form990PartVIISectionAGrp/OfficerInd3X
IRS990/Form990PartVIISectionAGrp/OfficerInd4X
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt00
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt10
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt20
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt30
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt40
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt50
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt60
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt70
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt80
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt90
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt100
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt110
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt120
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt130
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt140
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt150
IRS990/Form990PartVIISectionAGrp/PersonNm0Arash T Debastani
IRS990/Form990PartVIISectionAGrp/PersonNm1Sarah Michel
IRS990/Form990PartVIISectionAGrp/PersonNm2Vicki Ellingrod
IRS990/Form990PartVIISectionAGrp/PersonNm3Donna Strum
IRS990/Form990PartVIISectionAGrp/PersonNm4Alberto Cuitino
IRS990/Form990PartVIISectionAGrp/PersonNm5Kelechi C Ogbonna
IRS990/Form990PartVIISectionAGrp/PersonNm6Eric L Barker
IRS990/Form990PartVIISectionAGrp/PersonNm7Barbara Timmermann
IRS990/Form990PartVIISectionAGrp/PersonNm8Philip Hritcko
IRS990/Form990PartVIISectionAGrp/PersonNm9James K Drennen
IRS990/Form990PartVIISectionAGrp/PersonNm10Vadim J Gurvich
IRS990/Form990PartVIISectionAGrp/PersonNm11Amy Pittinger
IRS990/Form990PartVIISectionAGrp/PersonNm12Kevin Cassel
IRS990/Form990PartVIISectionAGrp/PersonNm13Wanda Maldonado
IRS990/Form990PartVIISectionAGrp/PersonNm14Martin S Zand
IRS990/Form990PartVIISectionAGrp/PersonNm15Paul Bryce
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt00
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt10
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt20
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt30
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt40
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt50
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt60
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt70
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt80
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt90
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt100
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt110
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt120
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt130
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt140
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt150
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt0492408
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt1420000
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt2416406
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt3411927
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt4400400
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt5386096
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt6337913
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt7318085
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt8311633
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt9256081
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt10169859
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt11152004
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt120
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt130
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt140
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt150
IRS990/Form990PartVIISectionAGrp/TitleTxt0Board Member
IRS990/Form990PartVIISectionAGrp/TitleTxt1Board Member
IRS990/Form990PartVIISectionAGrp/TitleTxt2Board Member
IRS990/Form990PartVIISectionAGrp/TitleTxt3Treasurer
IRS990/Form990PartVIISectionAGrp/TitleTxt4Board Member
IRS990/Form990PartVIISectionAGrp/TitleTxt5Secretary
IRS990/Form990PartVIISectionAGrp/TitleTxt6Board Member
IRS990/Form990PartVIISectionAGrp/TitleTxt7Board Member
IRS990/Form990PartVIISectionAGrp/TitleTxt8Vice Chair
IRS990/Form990PartVIISectionAGrp/TitleTxt9Chair
IRS990/Form990PartVIISectionAGrp/TitleTxt10Exective Director
IRS990/Form990PartVIISectionAGrp/TitleTxt11Board Member
IRS990/Form990PartVIISectionAGrp/TitleTxt12Board Member
IRS990/Form990PartVIISectionAGrp/TitleTxt13Board Member
IRS990/Form990PartVIISectionAGrp/TitleTxt14Board Member
IRS990/Form990PartVIISectionAGrp/TitleTxt15Board Member
IRS990/Form990ProvidedToGvrnBodyInd01
IRS990/FormationYr02007
IRS990/FormerOfcrEmployeesListedInd00
IRS990/FSAuditedInd00
IRS990/FundraisingActivitiesInd00
IRS990/FundraisingAmt00
IRS990/GainOrLossGrp/OtherAmt00
IRS990/GainOrLossGrp/SecuritiesAmt00
IRS990/GamingActivitiesInd00
IRS990/GoverningBodyVotingMembersCnt015
IRS990/GovernmentGrantsAmt01572465
IRS990/GrantAmt03663653
IRS990/GrantsPayableGrp/BOYAmt0479093
IRS990/GrantsToDomesticOrgsGrp/ProgramServicesAmt02888651
IRS990/GrantsToDomesticOrgsGrp/TotalAmt02888651
IRS990/GrantsToIndividualsInd00
IRS990/GrantsToOrganizationsInd01
IRS990/GrantToRelatedPersonInd00
IRS990/GrossReceiptsAmt03032204
IRS990/GroupReturnForAffiliatesInd00
IRS990/IncludeFIN48FootnoteInd00
IRS990/IncmFromInvestBondProceedsGrp/ExclusionAmt00
IRS990/IncmFromInvestBondProceedsGrp/RelatedOrExemptFuncIncomeAmt00
IRS990/IncmFromInvestBondProceedsGrp/TotalRevenueColumnAmt00
IRS990/IncmFromInvestBondProceedsGrp/UnrelatedBusinessRevenueAmt00
IRS990/IndependentAuditFinclStmtInd00
IRS990/IndependentVotingMemberCnt00
IRS990/IndivRcvdGreaterThan100KCnt00
IRS990/IndoorTanningServicesInd00
IRS990/InfoInScheduleOPartVIInd0X
IRS990/InfoInScheduleOPartXIIInd0X
IRS990/InformationTechnologyGrp/ManagementAndGeneralAmt0903
IRS990/InformationTechnologyGrp/ProgramServicesAmt08127
IRS990/InformationTechnologyGrp/TotalAmt09030
IRS990/InsuranceGrp/ManagementAndGeneralAmt01668
IRS990/InsuranceGrp/TotalAmt01668
IRS990/InvestmentExpenseAmt00
IRS990/InvestmentIncomeGrp/ExclusionAmt048079
IRS990/InvestmentIncomeGrp/RelatedOrExemptFuncIncomeAmt00
IRS990/InvestmentIncomeGrp/TotalRevenueColumnAmt048079
IRS990/InvestmentIncomeGrp/UnrelatedBusinessRevenueAmt00
IRS990/InvestmentInJointVentureInd00
IRS990/IRPDocumentCnt02
IRS990/IRPDocumentW2GCnt00
IRS990/LegalDomicileStateCd0IN
IRS990/LoanOutstandingInd00
IRS990/LobbyingActivitiesInd00
IRS990/LocalChaptersInd00
IRS990/MaterialDiversionOrMisuseInd00
IRS990/MembershipDuesAmt0295000
IRS990/MembersOrStockholdersInd01
IRS990/MethodOfAccountingAccrualInd0X
IRS990/MinutesOfCommitteesInd01
IRS990/MinutesOfGoverningBodyInd01
IRS990/MiscellaneousRevenueGrp/ExclusionAmt00
IRS990/MiscellaneousRevenueGrp/RelatedOrExemptFuncIncomeAmt00
IRS990/MiscellaneousRevenueGrp/TotalRevenueColumnAmt00
IRS990/MiscellaneousRevenueGrp/UnrelatedBusinessRevenueAmt00
IRS990/MissionDesc0The National Institute for Pharmaceutical Technology and Education (NIPTE) is a premier consortium of top universities working to advance pharmaceutical science, technology, and manufacturing. We collaborate with industry and regulatory agencies to drive innovation, enhance drug development efficiency, and strengthen the pharmaceutical workforce. Our research and education initiatives support modernized manufacturing, regulatory science, and supply chair resilience-ensuring safer, more effective, and more accessible medicines for patients. Through NIPTE, industry leaders and policymakers gain access to cutting-edge science and highly skilled talent pipeline, fostering a more robust and competitive pharmaceutical sector.
IRS990/MoreThan5000KToIndividualsInd00
IRS990/MoreThan5000KToOrgInd01
IRS990/NetAssetsOrFundBalancesBOYAmt0604894
IRS990/NetAssetsOrFundBalancesEOYAmt0482287
IRS990/NetUnrelatedBusTxblIncmAmt00
IRS990/NetUnrlzdGainsLossesInvstAmt00
IRS990/NoDonorRestrictionNetAssetsGrp/BOYAmt0604894
IRS990/NoDonorRestrictionNetAssetsGrp/EOYAmt0482287
IRS990/NoncashContributionsAmt00
IRS990/NondeductibleContributionsInd00
IRS990/OccupancyGrp/ManagementAndGeneralAmt02220
IRS990/OccupancyGrp/TotalAmt02220
IRS990/OfficeExpensesGrp/ManagementAndGeneralAmt0241
IRS990/OfficeExpensesGrp/ProgramServicesAmt02165
IRS990/OfficeExpensesGrp/TotalAmt02406
IRS990/OfficerMailingAddressInd00
IRS990/OperateHospitalInd00
IRS990/Organization501c3Ind0X
IRS990/OrganizationFollowsFASB117Ind0X
IRS990/OtherChangesInNetAssetsAmt00
IRS990/OtherExpensesGrp/Desc0Membership Fees
IRS990/OtherExpensesGrp/FundraisingAmt00
IRS990/OtherExpensesGrp/ManagementAndGeneralAmt00
IRS990/OtherExpensesGrp/ProgramServicesAmt040000
IRS990/OtherExpensesGrp/TotalAmt040000
IRS990/OtherLiabilitiesGrp/EOYAmt023940
IRS990/OtherRevenueMiscGrp/BusinessCd0900099
IRS990/OtherRevenueMiscGrp/Desc0Other Revenue
IRS990/OtherRevenueMiscGrp/ExclusionAmt0492
IRS990/OtherRevenueMiscGrp/RelatedOrExemptFuncIncomeAmt00
IRS990/OtherRevenueMiscGrp/TotalRevenueColumnAmt0492
IRS990/OtherRevenueMiscGrp/UnrelatedBusinessRevenueAmt00
IRS990/OtherRevenueTotalAmt0492
IRS990/PartialLiquidationInd00
IRS990/PayPremiumsPrsnlBnftCntrctInd00
IRS990/PledgesAndGrantsReceivableGrp/BOYAmt0304859
IRS990/PledgesAndGrantsReceivableGrp/EOYAmt02150049
IRS990/PoliticalCampaignActyInd00
IRS990/PrincipalOfficerNm0Vadim J Gurvich
IRS990/PriorPeriodAdjustmentsAmt0833110
IRS990/ProfessionalFundraisingInd00
IRS990/ProgramServiceRevenueGrp/BusinessCd0541700
IRS990/ProgramServiceRevenueGrp/BusinessCd1541700
IRS990/ProgramServiceRevenueGrp/Desc0Federal Research Contract
IRS990/ProgramServiceRevenueGrp/Desc1Freeze Drying Conference
IRS990/ProgramServiceRevenueGrp/ExclusionAmt00
IRS990/ProgramServiceRevenueGrp/ExclusionAmt10
IRS990/ProgramServiceRevenueGrp/RelatedOrExemptFuncIncomeAmt01047268
IRS990/ProgramServiceRevenueGrp/RelatedOrExemptFuncIncomeAmt125000
IRS990/ProgramServiceRevenueGrp/TotalRevenueColumnAmt01047268
IRS990/ProgramServiceRevenueGrp/TotalRevenueColumnAmt125000
IRS990/ProgramServiceRevenueGrp/UnrelatedBusinessRevenueAmt00
IRS990/ProgramServiceRevenueGrp/UnrelatedBusinessRevenueAmt10
IRS990/ProhibitedTaxShelterTransInd00
IRS990/PYBenefitsPaidToMembersAmt00
IRS990/PYContributionsGrantsAmt01280673
IRS990/PYExcessBenefitTransInd00
IRS990/PYGrantsAndSimilarPaidAmt01181569
IRS990/PYInvestmentIncomeAmt028761
IRS990/PYOtherExpensesAmt0380976
IRS990/PYOtherRevenueAmt04978
IRS990/PYProgramServiceRevenueAmt0171329
IRS990/PYRevenuesLessExpensesAmt0-76804
IRS990/PYSalariesCompEmpBnftPaidAmt00
IRS990/PYTotalExpensesAmt01562545
IRS990/PYTotalProfFndrsngExpnsAmt00
IRS990/PYTotalRevenueAmt01485741
IRS990/QuidProQuoContributionsInd00
IRS990/RcvFndsToPayPrsnlBnftCntrctInd00
IRS990/ReconcilationRevenueExpnssAmt0-955717
IRS990/RegularMonitoringEnfrcInd00
IRS990/RelatedEntityInd01
IRS990/RelatedOrganizationCtrlEntInd00
IRS990/RelatedOrganizationsAmt00
IRS990/RentalIncomeOrLossGrp/PersonalAmt00
IRS990/RentalIncomeOrLossGrp/RealAmt00
IRS990/ReportInvestmentsOtherSecInd00
IRS990/ReportLandBuildingEquipmentInd00
IRS990/ReportOtherAssetsInd00
IRS990/ReportOtherLiabilitiesInd01
IRS990/ReportProgramRelatedInvstInd00
IRS990/RevenueAmt01072268
IRS990/RoyaltiesRevenueGrp/ExclusionAmt00
IRS990/RoyaltiesRevenueGrp/RelatedOrExemptFuncIncomeAmt00
IRS990/RoyaltiesRevenueGrp/TotalRevenueColumnAmt00
IRS990/RoyaltiesRevenueGrp/UnrelatedBusinessRevenueAmt00
IRS990/SavingsAndTempCashInvstGrp/BOYAmt0945680
IRS990/SavingsAndTempCashInvstGrp/EOYAmt01122544
IRS990ScheduleA/Form990SchASupportingOrgGrp/Contribution35ControlledInd00
IRS990ScheduleA/Form990SchASupportingOrgGrp/ContributionControllerInd00
IRS990ScheduleA/Form990SchASupportingOrgGrp/ContributionFamilyInd00
IRS990ScheduleA/Form990SchASupportingOrgGrp/ControlDecidingGrntFrgnOrgInd01
IRS990ScheduleA/Form990SchASupportingOrgGrp/ControlledDisqualifiedPrsnInd00
IRS990ScheduleA/Form990SchASupportingOrgGrp/DisqualifiedPrsnControllIntInd00
IRS990ScheduleA/Form990SchASupportingOrgGrp/DisqualifiedPrsnOwnrIntInd00
IRS990ScheduleA/Form990SchASupportingOrgGrp/ExcessBusinessHoldingsRulesInd00
IRS990ScheduleA/Form990SchASupportingOrgGrp/ListedByNameGoverningDocInd00
IRS990ScheduleA/Form990SchASupportingOrgGrp/LoanDisqualifiedPersonInd00
IRS990ScheduleA/Form990SchASupportingOrgGrp/OrganizationChangeSuprtOrgInd01
IRS990ScheduleA/Form990SchASupportingOrgGrp/PaymentSubstantialContribtrInd00
IRS990ScheduleA/Form990SchASupportingOrgGrp/SupportedOrgClassDesignatedInd01
IRS990ScheduleA/Form990SchASupportingOrgGrp/SupportedOrgNotOrganizedUSInd01
IRS990ScheduleA/Form990SchASupportingOrgGrp/SupportedOrgSectionC456Ind00
IRS990ScheduleA/Form990SchASupportingOrgGrp/SupportForeignOrgNoDetermInd01
IRS990ScheduleA/Form990SchASupportingOrgGrp/SupportNonSupportedOrgInd01
IRS990ScheduleA/Form990SchASupportingOrgGrp/SuprtOrgNoIRSDeterminationInd00
IRS990ScheduleA/Form990SchAType1SuprtOrgGrp/OperateBenefitNonSuprtOrgInd00
IRS990ScheduleA/Form990SchAType1SuprtOrgGrp/PowerAppointMajorityDirTrstInd01
IRS990ScheduleA/Form990ScheduleAPartVIGrp/ExplanationTxt0The Articles of Incorporation included the original (11) supported organizations. The Board of Directors may, from time to time, by resolution adopted by two-thirds (2/3) of the directors then in office, permit the addition or substitution of new supported organizations that are institutions of higher learning described in code section 509(A)(1) or 509(A)(2). A supported organization may at any time withdraw its status as a supported organization of the corporation by delivering to the Board of Directors of the corporation written notice of such withdrawal signed by the director appointed by the withdrawing supported organization.
IRS990ScheduleA/Form990ScheduleAPartVIGrp/ExplanationTxt1The foreign organizations are a Belgian research university called the University of Liege and Foundation for Innovation and Technology Transfer in New Delhi, India. The funds are approved by the US Food and Drug Administration (FDA) as part of a scientific award to NIPTE. The organization controls the use of funds through detailed invoices and periodic reports, written and face-to-face presentations, submitted by the foreign organization to both NIPTE and the FDA.
IRS990ScheduleA/Form990ScheduleAPartVIGrp/ExplanationTxt2The organization controls the use of funds through detailed invoices and periodic reports, written and face-to-face presentations, submitted by the foreign organization to both NIPTE and the FDA.
IRS990ScheduleA/Form990ScheduleAPartVIGrp/ExplanationTxt3Two institutions of higher learning were added in fiscal year 2024 as supported organizations. They are Northeastern University (EIN 04-1679980) and Foundation for Innovation and Technology Transfer (EIN 99-9999999, not required as a foreign entity). The institutions were added to support pharmaceutical research under the FDA grant. The articles of incorporation allows additional supported organizations to be added that are institutions of higher learning and these institutions were added by approval of the subgrant awards by the board.
IRS990ScheduleA/Form990ScheduleAPartVIGrp/ExplanationTxt4There was one foreign university added in fiscal year 2024 which was the Foundation for Innovation and Technology Transfer.
IRS990ScheduleA/Form990ScheduleAPartVIGrp/FormAndLineReferenceDesc0Schedule A, Part IV, Section A, Line 1
IRS990ScheduleA/Form990ScheduleAPartVIGrp/FormAndLineReferenceDesc1Schedule A, Part IV, Section A, Line 4b
IRS990ScheduleA/Form990ScheduleAPartVIGrp/FormAndLineReferenceDesc2Schedule A, Part IV, Section A, Line 4c
IRS990ScheduleA/Form990ScheduleAPartVIGrp/FormAndLineReferenceDesc3Schedule A, Part IV, Section A, Line 5a
IRS990ScheduleA/Form990ScheduleAPartVIGrp/FormAndLineReferenceDesc4Schedule A, Part IV, Section A, Line 6
IRS990ScheduleA/IRSWrittenDeterminationInd0X
IRS990ScheduleA/OtherSupportSumAmt00
IRS990ScheduleA/SupportedOrganizationsCnt022

Document Assets

No mirrored PDF or thumbnail assets are attached yet.